Dinuceloside polyphosphates for the treatment of pain

摘要

The invention provides a dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use in the inhibition (or down-regulation) of a pain, via a transducing ATP -gated P2X3 receptor, often by means of high-affinity desensitisation (HAD) mechanism.